Finance

Lists
JAGSNPHARM:NSE
Jagsonpal Pharmaceuticals Ltd
217,86 INR
-0,57%
(-1,24) 1D
16-окт., 09:55:57 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JAGSNPHARM...
Open
220,70 INR
High
222,24 INR
Low
217,20 INR
Mkt. cap
14,39 млд
Avg. vol.
417,49 миң
Volume
5,49 миң
Dividend
1,15%
Quarterly dividend
0,62 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
32,35
52-wk high
264,50 INR
52-wk low
155,00 INR
EPS
6,73 INR
Shares outstanding
26,20 млн
No. of employees
1 миң
Open
220,70 INR
High
222,24 INR
Low
217,20 INR
Mkt. cap
14,39 млд
Avg. vol.
417,49 миң
Volume
5,49 миң
Dividend
1,15%
Quarterly dividend
0,62 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
32,35
52-wk high
264,50 INR
52-wk low
155,00 INR
EPS
6,73 INR
Shares outstanding
26,20 млн
No. of employees
1 миң
News stories
From web sources and news partners
About Jagsonpal Pharmaceuticals Ltd
CEO-
Employees1,3 миң
Founded1978
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 30-июл.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
822,32 млн / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
744,65 млн
729,45 млн
642,03 млн
822,32 млн
Cost of goods sold
272,28 млн
264,53 млн
249,67 млн
286,24 млн
Cost of revenue
272,28 млн
264,53 млн
249,67 млн
286,24 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
165,46 млн
172,95 млн
397,81 млн
227,78 млн
Operating expense
331,89 млн
326,10 млн
303,96 млн
385,10 млн
Total operating expenses
604,17 млн
590,63 млн
553,63 млн
671,34 млн
Operating income
140,48 млн
138,82 млн
88,40 млн
150,98 млн
Other non operating income
30,27 млн
29,75 млн
-87,71 млн
28,33 млн
EBT including unusual items
168,10 млн
145,21 млн
117,56 млн
176,80 млн
EBT excluding unusual items
168,10 млн
166,00 млн
117,56 млн
176,80 млн
Income tax expense
42,36 млн
35,70 млн
29,94 млн
44,91 млн
Effective tax rate
25,20%
24,59%
25,47%
25,40%
Other operating expenses
126,28 млн
126,45 млн
-82,94 млн
135,90 млн
Net income
125,74 млн
109,51 млн
87,62 млн
131,89 млн
Net profit margin
16,89%
15,01%
13,65%
16,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
117,43 млн
-
Interest expense
-2,65 млн
-2,57 млн
-560,00 миң
-2,51 млн
Net interest expenses
-2,65 млн
-2,57 млн
116,87 млн
-2,51 млн
Depreciation and amortization charges
23,86 млн
23,86 млн
23,19 млн
21,42 млн
EBITDA
164,18 млн
155,55 млн
108,00 млн
174,59 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору